KH 001 - HysensBio
Alternative Names: KH-001 - HysensBioLatest Information Update: 21 Jun 2024
At a glance
- Originator HysensBio
- Class Anti-infectives; Antiallergics; Peptides
- Mechanism of Action Odontoblast stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Dental caries; Hypersensitivity